J. Safra Sarasin Holding’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101M Buy
987,390
+26,676
+3% +$3.12M 1.45% 13
2026
Q1
$116M Buy
960,714
+40,289
+4% +$4.65M 1.97% 7
2025
Q4
$96.9M Buy
920,425
+148,461
+19% +$13.9M 1.58% 13
2025
Q3
$64.8M Sell
771,964
-9,352
-1% -$770K 1.05% 25
2025
Q2
$61.8M Sell
781,316
-32,786
-4% -$2.61M 1.07% 29
2025
Q1
$73.1M Buy
814,102
+19,540
+2% +$1.82M 1.32% 21
2024
Q4
$79M Sell
794,562
-168,135
-17% -$17.3M 1.34% 15
2024
Q3
$109M Buy
962,697
+93,767
+11% +$11.1M 1.9% 6
2024
Q2
$108M Buy
+868,930
New +$112M 1.96% 5

Other funds holding MRK

J. Safra Sarasin Holding's MRK Position: Q2 2026 in Review

J. Safra Sarasin Holding increased its Merck (MRK) stake by 2.8% in Q2 2026, buying an estimated $3.12M and bringing the position to 987,390 shares worth $101M. The position accounts for 1.45% of the portfolio, ranked #13.

J. Safra Sarasin Holding first reported a position in MRK in Q2 2024 and has held it in 9 quarters since. The position peaked at $116M in Q1 2026. 3,854 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • J. Safra Sarasin Holding held 987,390 shares of Merck worth $101M as of Q2 2026.
  • J. Safra Sarasin Holding bought 26,676 Merck shares in Q2 2026, an estimated $3.12M.
  • Merck made up 1.45% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #13 holding.
  • J. Safra Sarasin Holding first reported a position in Merck in Q2 2024 and has held it in 9 quarters since.
  • J. Safra Sarasin Holding's Merck position peaked at $116M in Q1 2026.
  • 3,854 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.